(Q51972908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Pamela Flodman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Robert B Wilson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Bert Gold

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Wayne W Grody

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

317-327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15915083%20AND%20SRC:MED&resulttype=core&format=json

Standards and guidelines for CFTR mutation testing

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Bayesian analysis and risk assessment in genetic counseling and testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Risk calculations: still essential in the molecular age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Newborn screening programmes for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

The relationship between neonatal immunoreactive trypsinogen, deltaF508, and IVS8-5T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

A Simple, Unified Approach to Bayesian Risk Calculations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Laboratory standards and guidelines for population-based cystic fibrosis carrier screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Genetic testing and risk assessment for spinal muscular atrophy (SMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Prenatal screening for cystic fibrosis: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A

Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000162871.68167.8A